Ambrx Biopharma, Inc.
AMAMDelisted Mar 7, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001990550
Ambrx Biopharma, Inc. was delisted on Mar 7, 2024; its insiders filed their last Form 4 on Mar 7, 2024; 68 institutions reported holding it in 13F filings for Q4 2023, worth $912.7M in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding Ambrx Biopharma, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 16 | 18 | +2 |
| Shares | 16.7M | 17.9M | +1.27M (+7.6%) |
| Value | $18.0M | $40.7M | +$22.7M (+126.2%) |
New holders (6)
Institutions that held Ambrx Biopharma, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Darwin Global Management, Ltd. | 7,584,489 | $17.2M | 10.72% |
| Alpine Global Management, LLC | 46,723 | $106.0K | 0.04% |
| National Asset Management, Inc. | 20,000 | $45.4K | 0.00% |
| Cubist Systematic Strategies, LLC | 17,905 | $40.6K | 0.00% |
| Simplex Trading, LLC | 11,045 | $25.0K | 0.00% |
| Cutler Group LP | 436 | $0 | 0.00% |
Sold out (4)
Institutions that held Ambrx Biopharma, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| BlackRock Inc. | 2,851,433 | $3.08M |
| Suvretta Capital Management, LLC | 1,491,832 | $1.61M |
| Royal Bank of Canada | 42,453 | $46.0K |
| Tudor Investment Corp Et Al | 16,315 | $18.0K |